Neurogenic Inflammation in Diabetes

NACompletedINTERVENTIONAL
Enrollment

41

Participants

Timeline

Start Date

May 31, 2012

Primary Completion Date

January 31, 2015

Study Completion Date

January 31, 2015

Conditions
Diabetes MellitusPolyneuropathiesArthropathy, Neurogenic
Interventions
OTHER

Intracutaneous injection of Candida albicans antigen.

Intracutaneous injection of 0.05 ml of four different concentrations of Candida albicans antigen on both the arm and foot.

OTHER

Temperature measurement.

Temperature measurement at the site of injection of the highest concentration of Candida albicans antigen on the foot and the same location on the contralateral foot using an infrared thermometer.

Trial Locations (1)

6202 AZ

Maastricht University Medical Center, Maastricht

Sponsors
All Listed Sponsors
collaborator

Dutch Diabetes Research Foundation

OTHER

lead

Maastricht University Medical Center

OTHER